HAWPY Stock: Haw Par Corporation Limited Stock Price, Analysis & Insights
Get live HAWPY stock price $53.50, comprehensive Haw Par Corporation Limited stock analysis, charts, news, and expert forecast. Real-time HAWPY stock data and investment insights.
Loading chart data...
Haw Par Corporation Limited (HAWPY) Overview
Haw Par Corporation Limited (HAWPY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, HAWPY trades at $53.50 with a market capitalization of 2.96B . Over the past 52 weeks, HAWPY has traded between $28.64 and $54.44 , with the current price positioned at approximately 96% of this range . The ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 2.96B
- Current price: $53.50
- 52-week range: $28.64 - $54.44
- P/E ratio: 14.27
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three...
Company Information
- CEO
- Ee Lim Wee
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 595
Contact Information
- Website
- https://www.hawpar.com
- Address
- No. 03-03 Haw Par Technocentre
- Country
- SG
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 14.3)
✓ Lower volatility stock (Beta: 0.16) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Haw Par Corporation Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Haw Par Corporation Limited
- ⚠Investors should consider how Haw Par Corporation Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
2.96B
P/E Ratio (TTM)
14.27
Beta
0.16
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HAWPY with peer companies:
- Price
- $8.77
- Market cap
- 3.89B
- Price
- $9.38
- Market cap
- 2.17B
- Price
- $1.35
- Market cap
- 3.27B
- Price
- $14.60
- Market cap
- 2.13B
- Price
- $42.59
- Market cap
- 2.07B
- Price
- $2.16
- Market cap
- 1.86B
- Price
- $3.98
- Market cap
- 2.80B
- Price
- $0.04
- Market cap
- 1.95B
- Price
- $12.22
- Market cap
- 3.93B
- Price
- $408.00
- Market cap
- 3.42B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.